Shanghai Tellgen Life Science
Pudong · Founded 2003
About Shanghai Tellgen Life Science
Tellgen provides medical products that include cardiovascular inflammatory markers, thyroid serum markers, tumor marker detection, biochemical reagent series products, multiple tumor marker controls, gene mutation detection products, flow cytometry fluorescence, DNA methylation detection products, Y chromosome microdeletion detection products, and human papillomavirus series detection.
Company Facts
- Founded: 2003
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $10K – $50K
- Total funding: $5.0M
- Funding stage: IPO
- Last round: Series A (Feb 2012)
- Ticker: szse:300642
- Website: tellgen.com
- Phone: 400-035-8689
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/shanghai-tellgen-life-science-1213881 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.